Notes
European Society for Medical Oncology
Reference
ESMO 2017. ESMO 2017 Press Release: Licensing and Reimbursement Discrepancies Impact Patient Access to Cancer Treatment. Internet Document : 10 Sep 2017. Available from: URL: http://www.esmo.org/Press-Office/Press-Releases/Licensing-and-Reimbursement-Discrepancies-Impact-Patient-Access-to-Cancer-Treatment
Rights and permissions
About this article
Cite this article
Licensing and reimbursement impact access to cancer drugs. PharmacoEcon Outcomes News 787, 26 (2017). https://doi.org/10.1007/s40274-017-4354-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-4354-4